ZUMA-2
Gilead Sciences
Gilead Sciences
Massachusetts General Hospital
Masonic Cancer Center, University of Minnesota
University of Chicago
Fred Hutchinson Cancer Center
Mayo Clinic
M.D. Anderson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
AstraZeneca
University of Michigan Rogel Cancer Center
UNC Lineberger Comprehensive Cancer Center
University of California, San Francisco
Masonic Cancer Center, University of Minnesota
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Gilead Sciences
Sana Biotechnology
M.D. Anderson Cancer Center
Gilead Sciences
University of Arizona
Case Comprehensive Cancer Center
City of Hope Medical Center
Sana Biotechnology
University of Maryland, Baltimore
Jonsson Comprehensive Cancer Center
Universität des Saarlandes
Roswell Park Cancer Institute
University of Miami
Masonic Cancer Center, University of Minnesota
Adicet Therapeutics
Peking University Cancer Hospital & Institute
City of Hope Medical Center
Fred Hutchinson Cancer Center
Thomas Jefferson University
City of Hope Medical Center
Miltenyi Biomedicine GmbH
Synthekine
Fred Hutchinson Cancer Center
University Hospital Heidelberg
City of Hope Medical Center
Academic and Community Cancer Research United
Roswell Park Cancer Institute
University of Nebraska
Masonic Cancer Center, University of Minnesota
University of Nebraska
University of Nebraska
Fate Therapeutics
TCR2 Therapeutics
National Institutes of Health Clinical Center (CC)
Fred Hutchinson Cancer Center